At the time of writing, Catheter Precision Inc. [VTAK] stock is trading at $0.53, up 16.06%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VTAK shares have gain 21.45% over the last week, with a monthly amount drifted -71.66%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Catheter Precision Inc. [AMEX: VTAK] stock has seen the most recent analyst activity on August 13, 2019, when Piper Jaffray downgraded its rating to a Neutral and also revised its price target to $1.50 from $9. Previously, Maxim Group started tracking the stock with Buy rating on November 02, 2018, and set its price target to $23.
For the past year, the stock price of Catheter Precision Inc. fluctuated between $0.38 and $8.40. Catheter Precision Inc. [AMEX: VTAK] shares were valued at $0.53 at the most recent close of the market.
Analyzing the VTAK fundamentals
According to Catheter Precision Inc. [AMEX:VTAK], the company’s sales were 0.44M for trailing twelve months, which represents an -3.13% plunge. Gross Profit Margin for this corporation currently stands at -0.26% with Operating Profit Margin at -24.45%, Pretax Profit Margin comes in at -21.77%, and Net Profit Margin reading is -21.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.5 and Total Capital is -0.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4703 points at the first support level, and at 0.4080 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5697, and for the 2nd resistance point, it is at 0.6068.
Ratios To Look Out For
It is important to note that Catheter Precision Inc. [AMEX:VTAK] has a current ratio of 0.12. Further, the Quick Ratio stands at 0.10, while the Cash Ratio is 0.0. Considering the valuation of this stock, the price to sales ratio is 3.39, the price to book ratio is 0.03.
Transactions by insiders
Recent insider trading involved JENKINS DAVID A, Executive Chairman and CEO, that happened on Jan 23 ’24 when 9528.0 shares were purchased. Executive Chairman and CEO, JENKINS DAVID A completed a deal on Jan 22 ’24 to buy 9528.0 shares. Meanwhile, Executive Chairman and CEO JENKINS DAVID A bought 8470.0 shares on Jan 19 ’24.
